Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs

被引：41

作者：

Shepherd, J ^{[1
]}

机构：

[1] Glasgow Royal Infirm, Inst Biochem, Glasgow G4 0SF, Lanark, Scotland

来源：

LANCET | 2002年 / 359卷 / 9325期

关键词：

D O I：

10.1016/S0140-6736(02)09299-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2271 / 2273

页数：3

共 14 条

[1] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[2] At what level of coronary heart disease risk should a statin be prescribed? [J].

Gaw, A ;

Packard, CJ .

CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (04) :363-367

[3] Primary prevention of coronary heart disease - Integrating risk assessment with intervention [J].

Grundy, SM .

CIRCULATION, 1999, 100 (09) :988-998

[4] Debate: at what level of coronary heart disease risk should a statin be prescribed? [J].

Jackson, PR ;

Ramsay, LE .

CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (04) :357-361

[5] Comparative dose efficacy study of Atorvastatin versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in patients with hypercholesterolemia (The CURVES study) [J].

Jones, P ;

Kafonek, S ;

Laurora, I ;

Hunninghake, D .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (05) :582-587

[6]

LaRosa JC, 1999, EUR HEART J SUPPL, V1, pJ18

[7]

Meade T, 1999, EUR HEART J, V20, P725

[8]

Packard CJ, 1998, CIRCULATION, V97, P1440

[9] PREVENTION OF CORONARY-HEART-DISEASE IN CLINICAL-PRACTICE - RECOMMENDATIONS OF THE TASK-FORCE OF THE EUROPEAN-SOCIETY-OF-CARDIOLOGY, EUROPEAN-ATHEROSCLEROSIS-SOCIETY AND EUROPEAN-SOCIETY-OF-HYPERTENSION [J].

PYORALA, K ;

DEBACKER, G ;

GRAHAM, I ;

POOLEWILSON, P ;

WOOD, D .

ATHEROSCLEROSIS, 1994, 110 (02) :121-161

[10]

ROSE G, 1991, J ROY COLL PHYS LOND, V25, P48

← 1 2 →